Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bydureon for Glucose Control in Type 1 Diabetes
NCT01928329Phase 2Completed
- Sponsor
- Yale University
- Start
- Sep 2013
- Primary completion
- Jun 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in type 1 diabetes mellitus (T1D), sponsored by Yale University. Started Sep 2013; status: completed.
02
Drugs
exenatide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01928329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928329.